$119 Million is the total value of Foresite Capital Management I, LLC's 8 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KPTI | Sell | Karyopharm Therapeutics Inc. | $64,118,000 | +30.9% | 1,377,410 | -13.1% | 53.75% | +56.2% |
| AMBI | Ambit Biosciences Corporation | $14,370,000 | -24.2% | 2,079,569 | 0.0% | 12.05% | -9.6% | |
| XNCR | Sell | Xencor, Inc. | $9,497,000 | -1.3% | 817,300 | -0.3% | 7.96% | +17.8% |
| ACRX | Sell | ACELRX Pharmaceuticals, Inc. | $8,692,000 | -47.5% | 847,983 | -38.5% | 7.29% | -37.4% |
| BDSI | BioDelivery Sciences International, Inc. | $8,449,000 | +43.0% | 700,000 | 0.0% | 7.08% | +70.7% | |
| OREX | Orexigen Therapeutics, Inc. | $7,725,000 | -4.9% | 1,250,000 | 0.0% | 6.48% | +13.5% | |
| RXDX | Ignyta, Inc. | $4,545,000 | +9.5% | 500,000 | 0.0% | 3.81% | +30.7% | |
| XLRN | Buy | Acceleron Pharma Inc. | $1,894,000 | +162.7% | 55,767 | +166.9% | 1.59% | +213.8% |
| NVAX | Exit | Novavax Inc.put | $0 | – | -2,000 | -100.0% | -0.64% | – |
| NVAX | Exit | Novavax Inc. | $0 | – | -1,336,200 | -100.0% | -4.25% | – |
| KERX | Exit | Keryx Biopharmaceuticals Inc. | $0 | – | -1,312,006 | -100.0% | -15.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Acceleron Pharma Inc. | 16 | Q3 2021 | 43.0% |
| 10X Genomics, Inc. | 12 | Q3 2022 | 100.0% |
| Epizyme, Inc. | 8 | Q1 2022 | 1.7% |
| Orexigen Therapeutics, Inc. | 7 | Q3 2015 | 44.3% |
| BioDelivery Sciences International, Inc. | 7 | Q3 2015 | 29.3% |
| Karyopharm Therapeutics Inc. | 5 | Q4 2014 | 55.1% |
| Xencor, Inc. | 5 | Q4 2014 | 13.8% |
| Novavax, Inc. | 5 | Q3 2021 | 10.8% |
| Ignyta, Inc. | 5 | Q1 2015 | 15.4% |
| Ambit Biosciences Corporation | 4 | Q3 2014 | 30.7% |
View Foresite Capital Management I, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-13 |
View Foresite Capital Management I, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.